FindTrial
Sign In

Reduced airway inflammation of smokers with statins

Reduced airway inflammation of smokers with statins - Reduced airway inflammation of smokers with statins

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001489
Enrollment
20
Registered
2008-11-08
Start date
2008-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

smokers COPD

Interventions

statins medication

Sponsors

Division of pumonary medicine,Department of Medicine, Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: smokers taking a bronchoscopic examination

Exclusion criteria

Exclusion criteria: patients with lver disfunction, renal disfunction or ischemic heart diseases patients taking medication which occurs drug interaction

Design outcomes

Primary

MeasureTime frame
inflammatory cytokines, chemokines and growth factors in the ELF—

Countries

Japan

Contacts

Public ContactTakahashi Saeko

Kawasaki minicipal hospital internal medicine

taksae@gf7.so-net.ne.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026